vs
Artisan Partners Asset Management Inc.（APAM）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Artisan Partners Asset Management Inc.的1.5倍（$493.8M vs $335.5M），Artisan Partners Asset Management Inc.净利率更高（35.2% vs 6.8%，领先28.4%），Artisan Partners Asset Management Inc.同比增速更快（12.9% vs -1.7%），过去两年Artisan Partners Asset Management Inc.的营收复合增速更高（12.7% vs -0.1%）
阿蒂森伙伴资产管理公司（Artisan Partners）是总部位于美国威斯康星州密尔沃基的资产管理机构，除美国本土外，还在都柏林、香港、伦敦、新加坡、悉尼设有办公室，为全球客户提供专业的资产管理服务。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
APAM vs MD — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $335.5M | $493.8M |
| 净利润 | $118.1M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | 39.2% | 9.9% |
| 净利率 | 35.2% | 6.8% |
| 营收同比 | 12.9% | -1.7% |
| 净利润同比 | 34.9% | 10.5% |
| 每股收益（稀释后） | $1.36 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $335.5M | $493.8M | ||
| Q3 25 | $301.3M | $492.9M | ||
| Q2 25 | $282.7M | $468.8M | ||
| Q1 25 | $277.1M | $458.4M | ||
| Q4 24 | $297.1M | $502.4M | ||
| Q3 24 | $279.6M | $511.2M | ||
| Q2 24 | $270.8M | $504.3M | ||
| Q1 24 | $264.4M | $495.1M |
| Q4 25 | $118.1M | $33.7M | ||
| Q3 25 | $66.8M | $71.7M | ||
| Q2 25 | $67.6M | $39.3M | ||
| Q1 25 | $61.1M | $20.7M | ||
| Q4 24 | $87.5M | $30.5M | ||
| Q3 24 | $73.0M | $19.4M | ||
| Q2 24 | $57.6M | $-153.0M | ||
| Q1 24 | $59.5M | $4.0M |
| Q4 25 | 39.2% | 9.9% | ||
| Q3 25 | 33.8% | 13.8% | ||
| Q2 25 | 28.2% | 12.8% | ||
| Q1 25 | 31.2% | 7.0% | ||
| Q4 24 | 36.7% | 7.8% | ||
| Q3 24 | 33.3% | 6.6% | ||
| Q2 24 | 32.0% | -31.3% | ||
| Q1 24 | 29.4% | 3.2% |
| Q4 25 | 35.2% | 6.8% | ||
| Q3 25 | 22.2% | 14.5% | ||
| Q2 25 | 23.9% | 8.4% | ||
| Q1 25 | 22.1% | 4.5% | ||
| Q4 24 | 29.5% | 6.1% | ||
| Q3 24 | 26.1% | 3.8% | ||
| Q2 24 | 21.3% | -30.3% | ||
| Q1 24 | 22.5% | 0.8% |
| Q4 25 | $1.36 | $0.40 | ||
| Q3 25 | $0.93 | $0.84 | ||
| Q2 25 | $0.94 | $0.46 | ||
| Q1 25 | $0.82 | $0.24 | ||
| Q4 24 | $0.99 | $0.37 | ||
| Q3 24 | $1.03 | $0.23 | ||
| Q2 24 | $0.80 | $-1.84 | ||
| Q1 24 | $0.84 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $375.2M |
| 总债务越低越好 | $190.0M | $570.5M |
| 股东权益账面价值 | $438.8M | $865.9M |
| 总资产 | $1.6B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.66× |
8季度趋势，按日历期对齐
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $190.0M | $570.5M | ||
| Q3 25 | $190.0M | $577.2M | ||
| Q2 25 | $200.0M | $583.9M | ||
| Q1 25 | $200.0M | $590.5M | ||
| Q4 24 | $200.0M | $597.1M | ||
| Q3 24 | $200.0M | — | ||
| Q2 24 | $200.0M | — | ||
| Q1 24 | $200.0M | — |
| Q4 25 | $438.8M | $865.9M | ||
| Q3 25 | $402.1M | $890.7M | ||
| Q2 25 | $381.8M | $833.8M | ||
| Q1 25 | $356.5M | $789.2M | ||
| Q4 24 | $388.9M | $764.9M | ||
| Q3 24 | $372.1M | $732.5M | ||
| Q2 24 | $341.2M | $706.5M | ||
| Q1 24 | $320.3M | $856.2M |
| Q4 25 | $1.6B | $2.2B | ||
| Q3 25 | $1.6B | $2.2B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.6B | $2.2B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $2.2B |
| Q4 25 | 0.43× | 0.66× | ||
| Q3 25 | 0.47× | 0.65× | ||
| Q2 25 | 0.52× | 0.70× | ||
| Q1 25 | 0.56× | 0.75× | ||
| Q4 24 | 0.51× | 0.78× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.0M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $171.6M | — |
| 自由现金流率自由现金流/营收 | 51.2% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.46× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $420.6M | — |
8季度趋势，按日历期对齐
| Q4 25 | $172.0M | $114.1M | ||
| Q3 25 | $40.4M | $137.3M | ||
| Q2 25 | $50.9M | $137.2M | ||
| Q1 25 | $157.9M | $-117.5M | ||
| Q4 24 | $372.8M | $133.0M | ||
| Q3 24 | $112.8M | $91.8M | ||
| Q2 24 | $75.9M | $107.0M | ||
| Q1 24 | $147.0M | $-125.2M |
| Q4 25 | $171.6M | — | ||
| Q3 25 | $40.4M | — | ||
| Q2 25 | $50.9M | — | ||
| Q1 25 | $157.7M | — | ||
| Q4 24 | $371.3M | — | ||
| Q3 24 | $112.4M | — | ||
| Q2 24 | $75.2M | — | ||
| Q1 24 | $146.9M | — |
| Q4 25 | 51.2% | — | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 125.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | 27.8% | — | ||
| Q1 24 | 55.6% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 1.46× | 3.39× | ||
| Q3 25 | 0.60× | 1.91× | ||
| Q2 25 | 0.75× | 3.49× | ||
| Q1 25 | 2.58× | -5.66× | ||
| Q4 24 | 4.26× | 4.36× | ||
| Q3 24 | 1.54× | 4.72× | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | 2.47× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APAM
暂无分部数据
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
